A poster presented at the 2025 ASCO Annual Meeting suggests that eligibility criteria for lung cancer clinical trials could be broadened without impacting survival outcomes. Physician’s Weekly spoke with investigator Michael May, MD, about the analysis and its implications for trial design. Dr. May: We were interested in whether the eligibility criteria within clinical trials […]
The post Only 35% Eligible: Who Gets Left Out of Lung Cancer Studies? first appeared on Physician’s Weekly.
